Starting on:
Jun 12, 2024
Ending on:
Jun 12, 2024
Moderator(s):
Venue:
KUTRRH
Max Credits:
3 Points
Provider:
Kenyatta University Teaching and Referral Hospital
Claim Points
Jun 12, 2024
Ending on:
Jun 12, 2024
Moderator(s):
KUTRRH
Max Credits:
3 Points
Provider:
Kenyatta University Teaching and Referral Hospital
Claim Points
ORAL HYPOGLYCEMIC AGENTS IN MANAGEMENT OF TYPE 2 DM
Starting on:
Jun 12, 2024
Jun 12, 2024
Ending on:
Jun 12, 2024
Jun 12, 2024
Venue:
KUTRRH
KUTRRH
Description
Type 2 diabetes mellitus consists of an array of dysfunctions characterized by hyperglycaemia and resulting from the combination of resistance to insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion.
Objectives
Goals of Type 2 DM management
Optimal glycemic control
Prevention of complications
Improvement in quality of life
Individualized treatment approach
Presenters
-
Dr.
KOROS JANET
DR